By: Judith L. Ladinsky, Ph.D., Harvey W. Gruchow, M.S., and Stanley L. Inhorn, M.D.
|
|
- Octavia Copeland
- 5 years ago
- Views:
Transcription
1 Cell Volume Distribution Pattern Analysis: A Means of Uterine Cancer Detection By: Judith L. Ladinsky, Ph.D., Harvey W. Gruchow, M.S., and Stanley L. Inhorn, M.D. Ladinsky J, Gruchow H, Inhorn S: Cell volume distribution pattern analysis as a means of uterine cancer detection. American Journal of Clinical Pathology, 54: , Made available courtesy of Lippincott Williams & Wilkins: ***Reprinted with permission. No further reproduction is authorized without written permission from Lippincott Williams & Wilkins. This version of the document is not the version of record. Figures and/or pictures may be missing from this format of the document.*** Abstract: The use of cell volume distribution pattern analysis as a semiautomated means of uterine cancer detection has been evaluated. The results of a study of 339 patients indicate that cell sizing effectively detects preinvasive lesions of the uterus. Compared with the Papanicolaou smear, cell volume distribution pattern analysis is as sensitive as the conventional technic in detecting invasive squamous-cell carcinoma of the cervix. However, for detection of adenocarcinoma of the endocervix and endometrium, cell sizing appears more than twice as sensitive as the conventional Ayre scrape. It was found that Trichomonas vaginalis under certain conditions acts as an interfering factor. From in vitro studies these conditions were determined and the means of eliminating the organism as a contaminant were considered. Article: The control of uterine cancer remains a vexing problem despite the proven reliability of the Papanicolaou smear. One of the difficulties lies in the qualitative nature of exfoliative cytology. Cells are classified not by measurements of cell parameters but by the judgment of experienced cytotechnologists. Their decision is based on a set of morphologic factors which are considered significant in distinguishing normal from malignant cells. It would be of considerable benefit if cell classification could be given a quantitative basis to eliminate the need for detailed visual inspection of each preparation. New quantitative methods in vaginal-cervical cytology must be developed if screening of large segments of the female population for cancer is to become a reality. When one calculates the amount of time necessary to screen hire population segments annually, the formidable nature of the problem becomes apparent. The present investigation was aimed at developing a new approach to the detection of uterine malignancy. The basic hypothesis of this approach is that there is a distinct difference between cell volumes of the cells exfoliated from the epithelia of normal patients and those desquamated from patients with various genital abnormalities. The previous absence of data concerning differences in total cell volumes has been due mainly to a lack of technology for accurate determinations. With the development of the electronic particle counter, precise quantitative data about the patterns of differential cell volumes in normal and malignant epithelia can now be achieved. The results of an initial study using cell volume distribution pattern analysis suggested that this technic might provide a rapid method for the detection of uterine malignancy. 13 In the initial study, it was found that Trichomonas vaginalis organisms under some conditions had the same volume distribution as the abnormal cells, resulting in false-positive readings. Following the initial study, an additional 339 patients were screened. The analysis and results of the expanded study and a discussion of T. vaginalis as an interfering factor are the subject of this report. Material and Methods The cell collections for this study were obtained from women who visited the Obstetrics and Gynecology Outpatient Clinics at the University of Wisconsin Medical Center, as well as patients admitted to the Gynecology Service of the Hospital. Since the University of Wisconsin Hospital is a referral institution, clinical
2 diagnoses were available prior to cell collection for most patients used in the study. These diagnoses served as a basis for analysis of the data. The cell samples were obtained at the time of speculum examination by instillation and aspiration of 5 ml. of Eagle's Minimum Essential Medium containing 10% fetal calf serum supplemented with penicillin and streptomycin. The cell collections were obtained with a Pipette fitted with a 5-ml, rubber bulb (Fig. 1). Fig. 1. Tube containing Eagle's medium and pipette fitted with 5-ml. bulb, used to obtain cell samples for size distribution analysis. (Bulb from the Bellco Glass Co., Vineland, N. J.) Retrieval of the medium from the vagina generally yielded approximately two to ten million desquamated cells. If the sample contained mucus, it was filtered through cheesecloth prior to processing. The collected cell samples were reagitated and diluted 1:50 with particle-free physiologic saline solution for counting and volume distribution analysis. In this study, all samples were analyzed within three hours of collection. Cell volume distribution pattern analyses were obtained by means of a model B Coulter Counter fitted with a 100-micron sampling aperture and a model H size distribution plotter. The theory and operation of the Coulter Counter have been described elsewhere. 1,10,15 The Coulter Counter was calibrated with ragweed pollen of known mean particle volume. Total cell counts were made at the setting having a volume range of 0 to 1,600 cup, using a lower threshold setting of 5 to screen out smaller debris and electronic noise, with the upper threshold disengaged. All volume distribution analyses were performed in duplicate: one at counter settings providing a volume distribution range of 0 to 1,600 cup; the other at a setting with a volume distribution range of 0 to 800 cup. For each patient, the collection of vaginal cells was preceded by acquisition of a smear which was analyzed in the Cytology Unit of the Wisconsin State Laboratory of Hygiene and reported as negative, atypical, suspicious, or positive. Patients were considered normal if they were asymptomatic and had normal cytology or negative biopsy findings, or both. Dysplasia, carcinoma in situ, and invasive carcinoma were diagnosed by tissue examination. No patient who had had a biopsy or curettage within a month prior to cell collection was included in the series. In this series a volume distribution pattern was considered abnormal if: (1) the population of large cells consisted of two or more peaks appearing after window 4 at the 0 to 1,600 cu. μ setting; (2) the population was present at the appropriate windows at a setting encompassing the 0 to 800 cu. μ range (for example, if the peak of the second population falls in window 8 at the 0 to 1,600 cu. μ setting, it must fall at approximately windows 15 or 16 at 0 to 800 cu. μ setting, and must contain twice the number of peaks at the latter setting as at the former); (3) the population was reproducible on an additional printout from the same sample. Trichomonas Vaginalis Cultures Vaginal pool samples from selected patients, proven by wet smear to have Trichomonas vaginitis, were collected, using a pipette. The samples were inoculated into 7 ml. of the liver extract culture medium of Feinberg and Wittington, 5 and incubated at 37 C. in an atmosphere of 95% air and 5% CO 2. Subcultures were made every three to four days after microscopic examination to ascertain viability.. After seven to ten days of
3 culture, size distributions of T. vaginalis were determined. At that time, the average cell count was 1.5 to 2.0 x 10 6 viable organisms per ml. Results Figure 2 illustrates two patterns as they were printed out by the size distribution plotter. On the left is a characteristic negative pattern from a normal patient. On the right is a characteristic positive pattern from a patient with invasive squamous-cell carcinoma of the cervix. In both patterns each peak represents the relative number of cells in that particular volume range. The cell volume increases from left to right. The patients studied totalled 339. As seen in Table 1, of 108 patients with negative smears, 75 had negative size distribution patterns and 33 had false-positive or abnormal size distribution patterns. However, 19 cases were unsatisfactory with the conventional smear due to insufficient numbers of cells, but were satisfactory for cell sizing because, with the latter technic, the cells are in suspension and the dilution factor for any particular specimen can be altered to obtain an adequate cell number for analysis, which is not possible with cell smears. An additional 16 patients (Table 1) with abnormal smears were found to have negative tissue findings. Of these 16, 12 had normal size distribution patterns and were classed as atypical with conventional cytology, and four patients had positive size distribution patterns. Three of these four had positive smears and one was classed as suspicious. Of 60 women shown to have dysplasia or carcinoma in situ confirmed by tissue examination, 40 had positive or abnormal top size distribution patterns (Table 2). smears made at the time of cell collection revealed 25 positive, seven suspicious, 12 atypical, and 15 false-negative smears, and one unsatisfactory smear. When dysplasia and carcinoma in situ were analyzed separately, 12 of the patients (85.7%) with dysplasia were detected by cell sizing, whereas the conventional technic found two positive, three suspicious, four atypical, and five negative. Of the 46 patients with carcinoma in situ, cell sizing was positive in 28 cases, whereas conventional cytology scored 23 positive, four suspicious, eight atypical, 10 negative; in one case an unsatisfactory smear was reported.
4 Of 96 patients (Table 3) with invasive squamous-cell carcinoma of the cervix, 82 patients (85.4%) were positive by cell sizing. The smear scored 62 of the 96 patients positive, eight suspicious, five atypical, and 13 negative. In eight cases, no smears were obtained at the time of cell collection. The 16 patients with squamous-cell carcinoma of the vagina and carcinoma of the ovary were obtained only incidentally. One might anticipate that the smear would not show any appreciable degree of accuracy in the detection of these lesions, because the smear samples are obtained by Ayre scrape of the cervix. Carcinoma of the ovary is thought to exfoliate only minimally, if at all, and it would seem unlikely for an appreciable number of cells to be obtained by cervical scraping. However, washing the vagina would increase the probability of collecting these cells if they were present. Surprisingly, the cell sizing technic detected only half the vaginal lesions, whereas the scrape did better. However, the cell sizing technic detected half the ovarian tumors, whereas the scrape missed all but one. There were 54 patients with the histologic diagnosis of adenocarcinoma of the endometrium (Table 4); of these, 50 (92.8%) had positive size distribution patterns, and four (7.2%) were negative. By the conventional smear 15 were positive, five suspicious, five atypical, and 22 negative, with seven not ascertained. Of five patients confirmed by tissue examination to have adenocarcinoma of the endocervix, all had abnormal size distribution patterns, and one was detected by conventional cytology. When the two adenocarcinoma categories are combined, size distributions were positive in 55 of 59 cases (93.2%), whereas the smear detected 26 of the 59 cases (44.4%).
5 Trichomonas Vaginalis as an Interfering Factor It was found in this study that when T. vaginalis organisms were present in vaginal washings, in some cases size distribution printouts similar to those which occur with uterine epithelial abnormalities were obtained. As can be seen in Figure 3A, the size distribution of a pure culture of T. vaginalis grown at ph 6.5 shows a unimodal population with a modal volume of 600 cu. μ. If a sample from a normal patient (Fig. 3B) is seeded with 1.0 to 1.5 x 10 6 organisms, it can easily be seen (Fig. 3C) that the size distribution pattern coincides with that of an abnormal cell population. It has been well established that the sizes of the Trichomonas organisms can increase or decrease with changes in ph, 11 so that in suitable instances the volumes of the organisms are small enough not to interfere with the abnormal cell patterns (Fig. 4). Viability of T. vaginalis in vitro is dependent not only on ph, but also on the presence of liver extract and certain other reagents in the medium. Therefore, if the ph of the collection medium (Eagle's medium with 10% fetal calf serum) is above ph 7.0 (Fig. 4A), and the organisms have been exposed to this medium for more than 20 hr., the volume of the organisms is such that they are beyond the volume range of the abnormal cell population. In the ph, range 7.0 to 8.0, if the Trichomonads are in Eagle's medium less than 20 hr. (Fig. 4B), they may appear as a unimodal population peaking at 500 to 600 cu. μ (Fig. 4C). It is within this ph range that the volumes of the organism coincide with that of the abnormal cell population and serve as an interfering factor in the system. Therefore, by having the collection medium above ph 7.0 or by analyzing the samples after 20 hr., Trichomonas vaginalis can be greatly reduced as an interfering factor.
6 Discussion The data suggest that cell sizing may provide a basis for a rapid method of detection of uterine malignancy. With minimal processing of the specimen after col. lection, the results can be obtained in approximately 200 sec. The high false-positive rate for cell sizing in this series may be partially explained by Trichomonas contamination. During in vitro studies with T. vaginalis, carried out simultaneously with this study and reported here, it was found that altering the ph of the collection medium can essentially eliminate Trichomonas contamination. When the ph of the collection medium was between 4.0 and 9.5, there was no change in the size distribution of the abnormal cell population present in vaginal washings collected from patients with squamouscell carcinoma of the cervix. In a subsequent field trial of cell sizing 12 in which this factor was controlled, it was found that the false-positive rate due to T. vaginalis group decreased from 25% to 2%. Of the 108 patients categorized as normal in Table 1, none had histologic confirmation. Therefore, it is conceivable that a portion of those categorized as cell size false-positive may in fact have some abnormality, but no verification was available. In considering the false-negative cases, it appears that repeated collections will reduce their importance, because successive negatives probably will not occur in the presence of significant abnormalities. Furthermore, the prolonged incipiency of in situ or lesser lesions affords time for such repetition. The present data, although from a limited number of patients, also indicate that the number of false negatives encountered with cell sizing is about the same as that with the cervical scrape. In the tables, the smears were classified as "negative," "atypical," suspicious, or "positive." While the suspicious and "positive" categories indicate the presence of cells thought to have arisen from a malignant lesion, the "atypical" category does not. The significance of the atypical smear depends upon the cytologic interpretation by the individual laboratory. In this laboratory the atypical classification is used to denote slight cytoplasmic or nuclear alterations in cellular morphology, associated in the majority of cases with inflammatory reactions such as cervicitis, vaginitis, or other benign conditions. This definition is shared by Taylor, 18 Slate, 18 Koss, 9 and Hulka. 7 Following a reading of "atypical," a repeat procedure is usually requested. Thus, it is difficult to determine whether the "atypical" classification should be included as a negative or classed with the positive categories when comparing two technics as to their accuracy in detecting malignancy. This ambiguity is a significant factor since the size distribution results are classified as either "positive" or "negative" and the relative sensitivity of the smear in detecting cervical abnormalities in relation to that of the size distribution method can be made more or less favorable depending on the disposition of the atypical category. The results of this study show that cell sixing efficiently detects preinvasive lesions of the uterus. This is evidenced by both histologic verification and correlation with the conventional smear. For detecting invasive squamous-cell carcinoma of the cervix, the two technics were about equally sensitive. However, for detecting adenocarcinoma of the endocervix and endometrium, cell sizing appeared to be more than twice as sensitive as the Ayre scrape. After the publication of the initial study of University of Wisconsin Hospitals patients screened by cell sizing, 13 the technic was attempted in other laboratories. Valliant and Richart 20 applied the technic of cell sizing to 65 women with cytologically established carcinoma in situ and dysplasia. Their patient sample was selected from those patients found on previous examination to have abnormal smears. Any patient who had negative cytology at the time of cell collection was excluded from the study. The cell collections were obtained by a physician using a Davis irrigation device 2 containing Eagle's
7 Minimum Essential Medium with penicillin and streptomycin. No serum, an ingredient found by us to be necessary for cell volume stability, was used in the medium. Valliant arid Richart 20 also found, in a series of ten patients, that the volume distribution of peripheral leukocytes was identical with the bimodal distribution of abnormal vaginal cell collections. Investigating this fact, they incubated both leukocytes and vaginal washings with Triton X-100, a stromatolyzing agent, and found that the second large cell population disappeared. They concluded that this large cell population, therefore, must have been leukocytes and not neoplastic cells. In an attempt to verify their findings, we obtained Triton X-100 from these authors and found that Triton X-I00 caused the malignant cells to dump, forming a clot of the cell suspension so that no epithelial cells were able to enter the aperture of the Coulter Counter (Figs. 5 to 7). Understandably, then, no second large cell populations were evident on the size distribution patterns. The fact that these authors found peripheral leukocytes collected in heparin to have the same size distribution pattern as the abnormal cells from vaginal washings is not in agreement with the findings of Ladinsky and Westrincg. 14 In a series of studies comparing normal and leukemic leukocytes obtained in a series of anticoagulants, it was found that peripheral Leukocytes obtained from normal subjects and those from patients with various solid tumors had a modal volume of 210 cu. μ. This is much smaller than the modal volumes of the abnormal cells found in patients with uterine abnormalities. These findings were corroborated by Gauthier and Harrel. 6 This difference in modal volume is great enough that leukocytes, in most cases, were found not to be interfering factors. It is interesting that just prior to their publication on cell sizing, Richart and Valliant 17 published a report on the Davis irrigation smear, in which they found a 50% false-negative rate for "presumptive" (cytologically proven) carcinoma in situ, a 51% false-negative rate for presumptive dysplasia, and a 39% (5 of 13) false-negative rate for histologically-proven carcinoma in situ. Despite the high false-negative rate found with the Davis irrigation device, these authors used the same device to evaluate cell sizing and found a 44% false-negative rate for cytologically-proven carcinoma in situ, a 60% false-negative rate for cytologically-proven dysplasia, and a 35% false-negative rate for histologically proven carcinoma in situ. In this study, of 274 patients classified as having carcinoma in situ and dysplasia, only 13 cases were histologically confirmed. The remaining 261 were diagnosed solely on the basis of the, smears, Therefore, there is a question whether these lesions were, in fact,
8 present; few laboratories are able to characterize the nature of a preinvasive lesion exactly on the basis of the smear alone. Fig. 6 (upper). Photomicrograph of a clot formed after cell suspension is exposed to Triton X-100 for 10 minutes. Note malignant cells surrounded by amorphous colloidal matter. stain. x 200. Fig. 7 (lower). Higher-power view of clot formed by Triton X-100. Note malignant cells emersed in colloidal matter. stain. x 300. It may be concluded that the Valliant and Richart study was not a repetition of our initial study, since the technics of collection and analysis were different and the data were, at best, equivocal.
9 In 1966, Iverson and associates 8 also attempted to test the method of cell sizing. However, these authors used an 0.3 M solution of isethionic acid as the collection fluid. A 10 ml. syringe furnished with a 4-inch, 16-gauge needle was placed 1 inch from the external os and under maximum pressure the fluid was instilled and aspirated from the posterior fornix. This procedure was repeated three times for each cell collection. These authors found, on screening 30 patients with carcinoma of the cervix, that 19 were positive (63.3%), and 11 were negative (36.7%). They also state that the "Coulter negative washings contained a large number of erythrocytes far in excess of any epithelial cell type." It is understandable that the harsh method of cell collection used by these authors caused bleeding which contaminated the "Coulter negative washings" excessively with erythrocytes. In an attempt to verify the findings of these authors, we analyzed duplicate washings from patients known to have invasive carcinoma of the cervix. One was collected and analyzed in tissue culture medium and the other in isethionic acid. In all cases, the second large cell population was found to be present in the specimens in which the cells were suspended in tissue culture medium and absent in the washings containing isethionic acid. It must be concluded that the Iverson study was not a repetition of our technic of cell sizing as originally published. On the other hand, Perez-Mesa and coworkers 16 made an independent study of cell sizing of 100 patients following our original method. They found 91% agreement between the smear interpretation and the size distribution curves. No false-normal curves were obtained. The false positives encountered were those associated with trichomoniasis. H. Davis in collaboration with A, Stafl, 4 after initial consultation with this laboratory, also attempted a corroborative study of cell sizing. Their patient sample included 34 patients with carcinoma in situ, 30 patients with invasive squamous-cell carcinoma of the cervix, and ten patients with adenocarcinoma of the endometrium. Their findings on cell sizing were: 79% accuracy for carcinoma in situ, 93% accuracy for invasive squamous-cell carcinoma of the cervix, and 90% accuracy for adenocarcinoma of the endometrium. Concerning those patients with carcinoma in situ, Davis 3 states that his classification is approximately equivalent to a diagnosis of dysplasia by most other pathologists. From the four studies described above in which the cell sizing method has been tested as a means for the detection of uterine cancer, the results from the first two can be questioned, since the methodology was in no way similar to the one used by us. The studies of Perez-Mesa and Davis, on the other hand, must be considered independent evaluations of the technic. Their results, although preliminary in that the patient samples were small, appear to corroborate the results of our study. The present findings indicate that cell volume distribution pattern analysis may prove useful as a mass prescreening technic. However, the patients used in this study, for the most part, had been diagnosed prior to the cell collection. To further evaluate the technic of cell sizing as a mass prescreening method, a limited field trial was undertaken in which 1,750 asymptomatic patients were screened. The results of the field trial are currently being ana1yied. 12 The advantages of cell sizing as a prescreening technic are: (1) the Coulter counter is commercially available, and its operation can be mastered by untrained personnel in a matter of days because the technic depends on semiautomated cell volume analysis rather than morphology; (2) the time involved in the preparation, analysis, and interpretation of the specimen is approximately 3 min.; (3) the elimination of the vast majority of negative patients now visually screened by conventional cytology would permit more effective use of trained cytotechnologists for screening of abnormal cytology. These studies suggest that the false-positive rate is acceptable for a screening technic and the false-negative rate may fall in the same range as that of the smear.
10 References 1. Bulletin T-1, Theory of the Coulter Counter. Coulter Electronics, Inc. 2. Davis, H. J.: The irrigation smear, a cytologic method for mass population screening by mail. Amer. J. Obstet. Gynec. 84: Y3, Davis, H. J.: Personal communication. 4. Davis, H. J., and Stafl, A.: Cell volume profiles of irrigation smears for automated uterine cancer screening. Obstet. Gynec. 32: , 5- Feinberg, J. G., and Whittington, M. J.: A culture medium for Trichomonas vaginalis Donne and species of candida. J. Clin, Path. 10: , Gauthier, J., and Harrel, P.: Human leukocytes: Their size distribution and mean corpuscular volume. Canad, Med. Ass. J. 97: , Hulka, B. S.: Cytologic and histologic outcome following an atypical smear. Amer, J. Obstet. Gynec. 101: , Iverson, S., Gordon, W. J., Cowell, M. A. C., and Watson, E. R.: Results from electronic determination of cell size distribution patterns in cervical washings. Brit. Med. J. 1: , Koss, L. G.: Diagnostic Pathology and Its Histopathologic Basis. Philadelphia, J. 11. Lippincott Co., Kubitschek, H. E.: Electronic measurement of particle size. Res. Appl. Ind. 13: , 1960, 11. Kupferberg, A. B.: Physiology of pure culture of Trichomonas vaginalis. II. Cell size and relation to ph. Proc, Soc. Exp. Biol. Med. 45: , Ladinsky, J. L.: Unpublished data. 13. Ladinsky, J. L., Sarto, G. E., and Peckham, B. M.: Cell size distribution patterns as a means of uterine cancer detection, J. Lab. Clin, Med. 64: , Ladinsky, J. L., and Westring, D. W.: The effect of anticoagulants on the volume of normal and leukemic leukocytes. Cancer Res, 27: , Mattern, C. F. T., Brackett, F. S., and Olson, B. J.: Determination of number and size of particles by electrical gating: Blood cells. J. Appl. Physiol. 10: 56-70, Perez-Mesa, C., Grubb, C., Johnson, R. E., and Yuen, P. S.: Preliminary results in the use of the Coulter counter Model B, as a means of detecting uterine cancer based on cell size distribution patterns. Ninth International Cancer Congress (abstract), Richart, R. M., and Valliant, H. W.: The irrigation smear-false negative rates in a population with cervical neoplasia. J.A.M.A. 192: , Slate, T. A.: The prevalence and significance of the class II smear in the routine screening for the detection of carcinoma of the cervix. Amer. J. Obstet. Gynec. 92: , Taylor, R. G. W.: Practical Cytology. New York, Academic Press, Valliant, H. W., and Richart, R. M.: An appraisal of the electronic particle counter as a screening technique for cervical neoplasia. Amer. J. Clin. Path. 45: , 1966.
Cervical Cancer Screening for the Primary Care Physician for Average Risk Individuals Clinical Practice Guidelines. June 2013
Cervical Cancer Screening for the Primary Care Physician for Average Risk Individuals Clinical Practice Guidelines General Principles: Since its introduction in 1943, Papanicolaou (Pap) smear is widely
More informationClinical Practice Guidelines June 2013
Clinical Practice Guidelines June 2013 General Principles: The Papanicolaou (Pap) smear is widely credited with reducing mortality from cervical cancer, and remains the single best method for the early
More informationInternational Journal of Biological & Medical Research
Int J Biol Med Res. ; 2(3): 757-761 Int J Biol Med Res www.biomedscidirect.com Volume 2, Issue 3, July BioMedSciDirect Publications Contents lists available at BioMedSciDirect Publications International
More informationDepartment of Pathology, Kathmandu Medical College & Teaching Hospital, Sinamangal, Kathmandu, Nepal
Kathmandu University Medical Journal (2007), Vol. 5, No. 4, Issue 20, 461-467 Original Article Correlation of PAP smear findings with clinical findings and cervical biopsy Pradhan B 1, Pradhan SB 2, Mital
More informationTHE INTERPRETATION OF INFLAMMATORY REACTIONS IN THE VAGINA, CERVIX, AND ENDOCERVIX BY MEANS OF CYTOLOGIC SMEARS
THE INTERPRETATION OF INFLAMMATORY REACTIONS IN THE VAGINA, CERVIX, AND ENDOCERVIX BY MEANS OF CYTOLOGIC SMEARS GEORGE L. WIED, M.D. Department of Obstetrics and Gynecology, University of Chicago and the
More informationInt. J. Life. Sci. Scienti. Res., 2(3): (ISSN: ) Impact Factor 2.4 MAY Research Article (Open access)
Int. J. Life. Sci. Scienti. Res., 2(3): -279-284 (ISSN: 2455-1716) Impact Factor 2.4 MAY-2016 Research Article (Open access) Detection of Abnormal Cervical Cytology by Papanicolaou Stained (PAP) Smears
More informationCervical Cancer : Pap smear
Taking a PAP SMEAR Cervical Cancer : Pap smear George N Papanicolaou introduced cervical cytology in clinical practice in 1940 In 1945, PAP smear was endorsed by American cancer society as an effective
More informationANALYSES OF CERVICAL CANCER IN RAJKOT POPULATION
Electronic Journal of Pharmacology and Therapy Vol 4, 15-20 (2011) ISSN: 0973-9890 (Available online at wwwtcrjournalscom) Clinical Article ndexed in: ProQuest database Abstract, USA (ProQuest Science
More informationSquamous cell carcinoma ofthe body of the uterus
J. clin. Path. (1965), 18, 715 Squamous cell carcinoma ofthe body of the uterus HANNA BARNETT' From the Department of Pathology, South London Hospital for Women, Clapham, London SYNOPSIS A case of primary
More informationMaking Sense of Cervical Cancer Screening
Making Sense of Cervical Cancer Screening New Guidelines published November 2012 Tammie Koehler DO, FACOG The incidence of cervical cancer in the US has decreased more than 50% in the past 30 years because
More informationCervical Precancer: Evaluation and Management
TAJ June 2002; Volume 15 Number 1 ISSN 1019-8555 The Journal of Teachers Association RMC, Rajshahi Review fam Cervical Precancer: Evaluation and Management SM Khodeza Nahar Begum 1 Abstract Carcinoma of
More informationFaculty Pap Smear Guidelines: Family Planning Update 2008 Part Two
Faculty Pap Smear Guidelines: Family Planning Update 2008 Part Two Seshu P. Sarma, MD, FAAP Emory University Regional Training Center Atlanta, Georgia Produced by the Alabama Department of Public Health
More informationbleeding Studies naar de diagnostiek van endom triumcarcinoom bij vrouwen met postm nopauzaal bloedverlies. Studies on the
Studies on the diagnosis of endometria cancer in women with postmenopausal bleeding. Studies naar de diagnostiek va endometriumcarcinoom bij vrouwen m postmenopauzaal bloedverlies. Studies on the diagnosis
More informationHistopathology: Cervical HPV and neoplasia
Histopathology: Cervical HPV and neoplasia These presentations are to help you identify basic histopathological features. They do not contain the additional factual information that you need to learn about
More informationEU guidelines for reporting gynaecological cytology
EU guidelines for reporting gynaecological cytology Amanda Herbert Guy s & St Thomas Foundation NHS Trust 5th EFCS Annual Tutorial, Trondheim, Norway 28 th May 1 st June 2012 EU guidelines aim to harmonize
More informationCourse Title: Thin Prep PAP Smears. Number of Clock Hours: 3 Course Title #
Course Title: Thin Prep PAP Smears Number of Clock Hours: 3 Course Title #5240303 Course Introduction There is a new laboratory test that is gaining popularity as a cancer screening tool for cervical cancer.
More informationCervical Testing and Results Management. An Evidenced-Based Approach April 22nd, Debora Bear, MSN, MPH
Cervical Testing and Results Management An Evidenced-Based Approach April 22nd, 2010 Debora Bear, MSN, MPH Assistant Medical Director for Planned Parenthood of New Mexico, Inc. Burden of cervical cancer
More informationJanuary 15, 2009 (202) PROPOSALS TO IMPROVE CYTOLOGY PROFICIENCY TESTING REQUIRED BY THE CLINICAL LABORATORY IMPROVEMENT AMENDMENTS OF 1988
DEPARTMENT OF HEALTH & HUMAN SERVICES Centers for Medicare & Medicaid Services Room 352-G 200 Independence Avenue, SW Washington, DC 20201 Office of Media Affairs CMS FACT SHEET FOR IMMEDIATE RELEASE Contact:
More informationCytology and Surgical Pathology of Gynecologic Neoplasms
Cytology and Surgical Pathology of Gynecologic Neoplasms Current Clinical Pathology ANTONIO GIORDANO, MD, PHD SERIES EDITOR For further titles published in this series, go to http://www.springer.com/springer/series/7632
More information!"#$%&'(#)*$+&,$-&.#,$/#0()1-$ ),1')$2(%&,2#,%$%(0'#$34567$
!"#$%&'(#)*$+&,$-&.#,$/#0()1-$ ),1')$2(%&,2#,%$%(0'#$34567$ Updated Consensus Guidelines for Managing Abnormal Cervical Cancer Screening Tests and Cancer Precursors American Society for and Cervical Pathology
More informationFluorescence Spectroscopy: A New Approach in Cervical Cancer
DOI 10.1007/s13224-012-0298-6 ORIGINAL ARTICLE : A New Approach in Cervical Cancer Pandey Kiran Pradhan Asima Agarwal Asha Bhagoliwal Ajay Agarwal Nidhi Received: 2 June 2008 / Accepted: 7 August 2012
More informationClinically Microscopically Pathogenesis: autoimmune not lifetime
Vulvar Diseases: Can be divided to non-neoplastic and neoplastic diseases. The neoplastic diseases are much less common. Of those, squamous cell carcinoma is the most common. most common in postmenopausal
More informationSignificance of Endometrial Cells in Cervicovaginal Smears
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 7,No. 6 Copyright 1977, Institute for Clinical Science Cervicovaginal Smears BERNARD GONDOS, M.D. and EILEEN B. KING, M.D. Department of Pathology, University
More informationSALINA PATHOLOGY LABORATORY
TABLE OF CONTENTS ================================================= REQUISITION... 2 SPECIMEN LABELING... 2 PAP SMEAR SPECIMEN COLLECTION... 3 Patient Preparation... 3 Sample Collection... 3 Placement
More informationCervicovaginal Cytology: Normal and Abnormal Cells and Adequacy of Specimens
Cervicovaginal Cytology: Normal and Abnormal Cells and Adequacy of Specimens 3 Christine Bergeron, MD, PhD Introduction Carcinoma of the cervix is a slow growing cancer, which is preceded by precancerous
More informationWorkshop for O& G trainees and paramedics 17 Dec 2011 Cytological Interpretation
Workshop for O& G trainees and paramedics 17 Dec 2011 Cytological Interpretation May Yu Director of Cytology Laboratory Service Department of Anatomical & Cellular Pathology Prince of Wales Hospital Cervical
More informationICD-9-CM to ICD-10-CM DIAGNOSIS CODE MAPPING. Central Valley Public Health: Women's Way
ICD-9-CM to ICD-10-CM DIAGNOSIS CODE MAPPING Central Valley Public Health: Women's Way ICD-9-CM (Top 35) ICD-10-CM ICD-10-CM Description COMMENTS V10.3: Personal history of malignant neoplasm of Z85.3
More informationBCCCP Approved ICD-9 Code List Fiscal Year 2010
BCCCP Approved ICD-9 List Fiscal Year 2010 Diagnosis Description 174.0 Malignant neoplasm of female breast; Nipple and areola 174.1 Malignant neoplasm of female breast; Central portion 174.2 Malignant
More informationComparative Study of Pap Smear Quality by using Ayre s Spatula versus Ayre s Spatula and Cytobrush Combination
ORIGINAL ARTICLE Comparative Study of Pap Smear Quality by using Ayre s Spatula versus Ayre s Spatula and Cytobrush Combination Numi Anjum 1, B Sindhoora 2 1. Tutor, Department of Obstetrics and Gynecology
More informationThe Pap Smear Test. The Lebanese Society of Obstetrics and Gynecology. Women s health promotion series
The Lebanese Society of Obstetrics and Gynecology Women s health promotion series The Pap Smear Test Since the Pap smear test started to be used the number of cases of cervical cancer was greatly reduced.
More informationDr. Issraa Ali Hussein
CLINICAL 09888888;rCYTOLOGY Dr. Issraa Ali Hussein objectives Define diagnostic cytology (clinical cytology). Explain the differences between histopathology and cytopathology. Recognize the methods for
More informationChapter 10: Pap Test Results
Chapter 10: Pap Test Results On completion of this section, the learner will be able to: 1. Identify how Pap test results are interpreted and the reasons for normal and abnormal results. 2. Describe the
More informationFellowship in Cytopathology Department of Pathology. All India Institute of Medical Sciences (AIIMS) Jodhpur, Rajasthan, India
Fellowship in Cytopathology Department of Pathology All India Institute of Medical Sciences (AIIMS) Jodhpur, Rajasthan, India Syllabus for Fellowship in Cytopathology: FNAC Direct, Guided, EUS Exfoliative
More informationSurvey of the results of the routine use of the vaginal smear in the detection of uterine cervical cancer in private patients
University of Nebraska Medical Center DigitalCommons@UNMC MD Theses College of Medicine 5-1-1964 Survey of the results of the routine use of the vaginal smear in the detection of uterine cervical cancer
More informationCervical Conization. 1
Cervical Conization www.zohrehyousefi.com 1 Cone Biopsy is a surgical procedure with removal of a cone shaped portion of the cervix The extent of involvement of epithelium on the ectocervix has been clearly
More informationThe ABCs of TBS. A Novice's Guide to the Bethesda System
CE U P D A T E W O M E N ' S HEALTH III Julia Woodruff Wildes, MD The ABCs of TBS A Novice's Guide to the Bethesda System This is the third and final article in a three-part series on women's health. The
More informationHistological Typing Of Cancer And Precancer Of The Oral Mucosa
Histological Typing Of Cancer And Precancer Of The Oral Mucosa 1 / 7 2 / 7 3 / 7 Histological Typing Of Cancer And Within the last decade, histologic grading has become widely accepted as a powerful indicator
More informationPAP SMEAR by Dr.Shantha Krishnamurthy MD Senior Consultant Pathology Fortis Hospitals
PAP SMEAR by Dr.Shantha Krishnamurthy MD Senior Consultant Pathology Fortis Hospitals Historical Named after George Papanicolaou, a Greek American Studied cervical epithelium in menstrual cycle of guinea
More informationBC Cancer Cervix Screening 2015 Program Results. February 2018
BC Cancer Cervix Screening 2015 Program Results BC Cancer Cervix Screening 2015 Program Results 2 Table of Contents BC Cancer Cervix Screening 2015 Program Results... 1 Table of Contents... 2 Program Overview...
More informationStudy of Cervical Pap Smears in a Tertiary Hospital
250 Original Study Study of Cervical Pap Smears in a Tertiary Hospital Sunita A. Bamanikar, Professor, Department of Pathology, Dadaso S. Baravkar, Resident Pathologist, Department of Pathology, Shirish
More informationThe society for lower genital tract disorders since 1964.
The society for lower genital tract disorders since 1964. Updated Consensus Guidelines for Managing Abnormal Cervical Cancer Screening Tests and Cancer Precursors American Society for and Cervical Pathology
More informationElectron Microscopy Sciences
Electron Microscopy Sciences INSTRUCTIONAL MANUAL CAT. #26750 Series EMS Rapid Pro Processing System Protocol: Cytology P.O. Box 550 s1560 Industry Road s Hatfield PA 19440 1 Cytology Protocol Cytologic
More informationWhat is endometrial cancer?
Uterine cancer What is endometrial cancer? Endometrial cancer is the growth of abnormal cells in the lining of the uterus. The lining is called the endometrium. Endometrial cancer usually occurs in women
More informationAn audit of liquid-based cervical cytology screening samples (ThinPrep and SurePath) reported as glandular neoplasia
DOI:10.1111/j.1365-2303.2009.00695.x An audit of liquid-based cervical cytology screening samples (ThinPrep and SurePath) reported as glandular neoplasia S. A. Thiryayi, J. Marshall and D. N. Rana Manchester
More informationAssociate Professor of Gyn. & Obs., Department of Gynecology and Obstetrics, Tehran University of Medical Sciences, Iran.
Assessment of Visual Inspection with Acetic Acid (VIA) as a Screening Test for Cervical Neoplasia in Comparison with Cytologic Screening in Imam Khomeini Hospital F. Ghaemmaghami, MD Associate Professor
More informationSperm Survival in Women. Motile Sperm in the Fundus and Tubes of Surgical Cases
Sperm Survival in Women Motile Sperm in the Fundus and Tubes of Surgical Cases Boris B. Rubenstein, M.D., Ph.D.; Hermann Strauss, M.D.; Maurice L. Lazarus, M.D., and Henry Hankin, M.D. THE DURATION of
More informationReceived, June 29, 1904; accepted for publication
THE AMEBICAN JOURNAL OF CLINICAL PATHOLOGY Copyright 1964 by The Williams & Wilkins Co. Vol. 42, No. 0 Printed in U.S.A. CARCINOMA IN SITU OF THE ENDOMETRIUM ISABELLE A. BUEHL, M.D., PRANK VELLIOS, M.D.,
More informationClinical Usefulness of Cervicogram as a Primary Screening Test for Cervical Neoplasia
Yonsei Medical Journal Vol. 46, No. 2, pp. 213-220, 2005 Clinical Usefulness of Cervicogram as a Primary Screening Test for Cervical Neoplasia Young Tae Kim 1,2, Jae Wook Kim 1,2, Sung Hoon Kim 1,2, Yu
More informationQuality control in cervical cytology
Quality control in cervical cytology 0. A. N. HUSAIN, E. BLANCHE BUTLER, D. M. D. EVANS1, J. ELIZABETH MACGREGOR, AND R. YULE J. clin. Path., 1974, 27, 935-944 From St Stephen's and Charing Cross Hospitals,
More informationLESION AT PACIFIC MEDICAL COLLEGE, UDAIPUR. 1. Assistant Professor, Department of Pathology, Pacific Medical college and hospital, Udaipur.
International Journal of Medical Science and Education An official Publication of Association for Scientific and Medical Education (ASME) Original Research Article HISTOPATHOLOGICAL AND CYTOLOGICAL ANALYSIS
More informationProfile Of Cervical Smears Cytology In Western Region Of Saudi Arabia
ISPUB.COM The Internet Journal of Gynecology and Obstetrics Volume 1 Number 2 Profile Of Cervical Smears Cytology In Western Region Of Saudi Arabia I Mansoor Citation I Mansoor. Profile Of Cervical Smears
More informationCytology/Biopsy/Leep Gynecologic Correlation: Practical Considerations and Approaches.
Cytology/Biopsy/Leep Gynecologic Correlation: Practical Considerations and Approaches. Fadi W. Abdul-Karim MD MEd. Professor of Pathology. Vice chair for education. Robert Tomsich Pathology and Lab Med
More informationA cyto-histopathological correlation study of lesions of uterine cervix
Original Research Article Mandakini B. Tengli 1,*, Mohammed Mateen Ahmed 2 1 Associate Professor, 2 Assistant Professor, Dept. of Pathology, KBNIMS, Gulbarga *Corresponding Author: Email: mandakinibt@gmail.com
More informationPreface to the Second Edition
Preface to the Second Edition This second edition of Diagnosis of Endometrial Biopsies and Curettings: A Practical Approach follows a number of favorable comments we received about the first edition. As
More informationRepeat Thyroid Nodule Fine-Needle Aspiration in Patients With Initial Benign Cytologic Results
Anatomic Pathology / REPEAT THYROID FINE-NEEDLE ASPIRATION Repeat Thyroid Nodule Fine-Needle Aspiration in Patients With Initial Benign Cytologic Results Melina B. Flanagan, MD, MSPH, 1 N. Paul Ohori,
More informationSummary CHAPTER 1. Introduction
Summary This thesis aims to evaluate the diagnostic work-up in postmenopausal women presenting with abnormal vaginal bleeding. The Society of Dutch Obstetrics and Gynaecology composed a guideline, which
More informationClinical Guidance: Recommended Best Practices for Delivery of Colposcopy Services in Ontario Best Practice Pathway Summary
Clinical Guidance: Recommended Best Practices for Delivery of Colposcopy Services in Ontario Best Practice Pathway Summary Glossary of Terms Colposcopy is the examination of the cervix, vagina and, in
More informationPlease complete prior to the webinar. HOSPITAL REGISTRY WEBINAR FEMALE REPRODUCTIVE SYSTEM EXERCISES CASE 1: FEMALE REPRODUCTIVE
Please complete prior to the webinar. HOSPITAL REGISTRY WEBINAR FEMALE REPRODUCTIVE SYSTEM EXERCISES PHYSICAL EXAMINATION CASE 1: FEMALE REPRODUCTIVE 3/5 Patient presents through the emergency room with
More informationPathology Specimen Handling Requirements
CONWAY REGIONAL HEALTH SYSTEM CLINICAL LABORATORY Pathology Specimen Handling Requirements POLICY: Tissue or body fluids, etc. removed or collected during any procedure for purposes of Pathologist examination
More informationMPH Quiz. 1. How many primaries are present based on this pathology report? 2. What rule is this based on?
MPH Quiz Case 1 Surgical Pathology from hysterectomy performed July 11, 2007 Final Diagnosis: Uterus, resection: Endometrioid adenocarcinoma, Grade 1 involving most of endometrium, myometrial invasion
More informationCervical Skills. Dr Margaret Laing Queen Elizabeth University Hospital
Cervical Skills Dr Margaret Laing Queen Elizabeth University Hospital What is screening? Screening is a test offered to an apparently well person with the possibility of detecting a serious disease before
More informationExperience of the Finnish mass screening system
British Journal of Preventive and Social Medicine, 1977, 31, 238-244 Selective screening for cervical cancer Experience of the Finnish mass screening system MATTI HAKAMA AND EERO PUKKALA From the Finnish
More informationABSTRACT 1. INTRODUCTION. Tajossadat Allameh 1, Somayeh Khanjani 2, Fereshteh Mohammadizadeh 3*, Elaheh Refaei 4. sions.
Open Journal of Obstetrics and Gynecology, 213, 3, 341-346 http://dx.doi.org/.4236/ojog.213.363 Published Online May 213 (http://www.scirp.org/journal/ojog/) OJOG Diagnostic of the combination of TruScreen
More informationCytopathology. Robert M Genta Pathologie Clinique Université de Genève
Cytopathology Robert M Genta Pathologie Clinique Université de Genève Learning objectives At the end of this hour you will know: 1. What cytopathology is 2. How specimens are collected, processed, and
More informationCASEFINDING. KCR Abstractor s Training
CASEFINDING KCR Abstractor s Training 1 Introduction Casefinding Definition Purpose Methods Sources vs Resources Reportable Cancer Conditions Non-Reportable Conditions Ambiguous Terminology 2 https://www.google.com/search?q=puzzle+pieces&client=firefox-a&hs=mdc&rls=org.mozilla
More informationMedicaid Family Planning Waiver Services CPT Codes and ICD-10 Diagnosis Codes
CPT Code Description of Covered Codes Evaluation and Management 99384FP 99385FP Family planning new visit 99386FP 99394FP 99395FP Family planning established visit 99396FP 99401FP HIV counseling (pre-test)
More informationRunning head: EVIDENCE-BASED MEDICINE TWO-STEP DISCREPANCY
Evidence-Based Medicine Two-Step Discrepancy 1 Running head: EVIDENCE-BASED MEDICINE TWO-STEP DISCREPANCY Evidence-Based Medicine Two-Step Discrepancy Julie Nelson Texas Woman s University Philosophy of
More informationPap Smears Pelvic Examinations Well Woman Examinations. When should you have them performed???
Pap Smears Pelvic Examinations Well Woman Examinations. When should you have them performed??? Arlene Evans-DeBeverly, PA-C Copyright 2012 There are always ongoing changes in gynecology, including the
More informationCELL-MEDIATED IMMUNITY TO ENCEPHALITOGENIC FACTOR (MMI TEST) IN WOMEN WITH CERVICAL DYSPLASIA AND CARCINOMA
Br. J. Cancer (1978) 38, 396 CELL-MEDIATED IMMUNITY TO ENCEPHALITOGENIC FACTOR (MMI TEST) IN WOMEN WITH CERVICAL DYSPLASIA AND CARCINOMA IN SITU: THE EFFECTS OF SERUM D. J. FLAVELL*l, A. SINGER2 AND C.
More informationvalue as a medium for the in vivo cultivation of different
THE BEHAVIOR OF THE VIRUS OF EQUINE ENCEPH- ALOMYELITIS ON THE CHORIOALLANTOIC MEMBRANE OF THE DEVELOPING CHICK' ELIZABETH HIGBIE AND BEATRICE HOWITT George Williams Hooper Foundation, University of California,
More informationSCREENING FOR CERVICAL CANCER BY PAP SMEAR
SCREENING FOR CERVICAL CANCER BY PAP SMEAR Pages with reference to book, From 229 To 231 Javaid H. Rizvi, Saadia Rasul, Basit Ghazali, Abid Jamal ( Department of Obstetrics and Gynaecology, The Aga Khan
More informationLesions of uterine cervix by cytology and histopathology- A prospective study for a period of two years
Original Research Article DOI: 10.18231/2394-6792.2017.0040 Lesions of uterine cervix by cytology and histopathology- A prospective study for a period of two years Deepthi KN 1,*, Aravinda Macharla 2 1,2
More informationUpdate on Thyroid FNA The Bethesda System. Shikha Bose M.D. Associate Professor Cedars Sinai Medical Center
Update on Thyroid FNA The Bethesda System Shikha Bose M.D. Associate Professor Cedars Sinai Medical Center Thyroid Nodules Frequent occurrence Palpable: 4-7% of adults Ultrasound: 10-31% Majority benign
More informationCervical Dysplasia and HPV
Cervical Dysplasia and HPV J. Anthony Rakowski D.O., F.A.C.O.O.G. MSU SCS Board Review Coarse HPV Double stranded DNA virus The HPV infect epithelial cells of the skin and mucous membranes Highest risk
More informationManagement that provides continuity of care for women
Management that provides continuity of care for women If women are diagnosed with reproductive tract infection, prompt treatment should be instituted according to the WHO guidelines. Though it may be preferred
More informationDiagnostically Challenging Cases in Gynecologic Pathology
Diagnostically Challenging Cases in Gynecologic Pathology Eric C. Huang, M.D., Ph.D. Department of Pathology and Laboratory Medicine University of California, Davis Medical Center Case 1 Presentation 38
More informationCASE 4 21/07/2017. Ectopic Prostatic Tissue in Cervix. Female 31. LLETZ for borderline nuclear abnormalities
Female 31 CASE 4 LLETZ for borderline nuclear abnormalities PSA Ectopic Prostatic Tissue in Cervix AJSP 2006;30;209-215 usually incidental microscopic finding usually in ectocervical stroma? developmental
More informationGOALS AND OBJECTIVES CYTOPATHOLOGY
GOALS AND OBJECTIVES CYTOPATHOLOGY LEVEL: PGY2, PGY4, PGY5 The 1st block in PGY2 is an introductory in nature and is followed by two more blocks in PGY-4 (please, see core rotation for PGY4 below) and
More informationQUALITY CONTROL IN CYTOLOGY
27 QUALITY CONTROL IN CYTOLOGY 27.1 INTRODUCTION Cytopathologists are concerned about and committed to quality assurance and quality control in their laboratories. These practices include, among others,
More informationDifferentiation of Tumors with Specific Red Cell Adherence (SRCA) test
753 Differentiation of Tumors with Specific Red Cell Adherence (SRCA) test Dr. Abhishek A Mangaonkar *, Dr. A G Valand 1 Intern, Grant Medical College and Sir J.J. Group of Hospitals, Mumbai, India 2 Professor,
More informationPap Smear and Histopathological Study of Cervical Lesions
Global Journal of Medical research: c Microbiology and Pathology Volume 14 Issue 4 Version 1.0 Year 2014 Type: Double Blind Peer Reviewed International Research Journal Publisher: Global Journals Inc.
More informationEfficacy of cervical intrarepithelial neoplasia (CIN)
The Ulster Medical Journal, Volume 72, No. 1, pp. 10-15, May 2003. Efficacy of cervical intrarepithelial neoplasia (CIN) treatment by cold coagulation A Zawislak, J H Price, H R McClelland, R G N Storey,
More informationand treating joins with the top of canal). at risk for cervical carcinomas, cervix.
CERVICAL CANCER Worldwide, cervical cancer is twelfth most common and the fifth most deadly cancer in women. It affects about 16 per 100,000 women per year and kills about 9 per 100,000 per year. Cervical
More informationIntroduction to Colposcopy
Introduction to Colposcopy Papanicolaou smear (Pap smear) screening test Colposcopy diagnostic test Introduction to Colposcopy Acetic acid and Lugol s iodine applied Cervix examined under magnification
More informationCERVICAL CANCER SCREENING IN BOTSWANA: A ROLE FOR TELEMEDICINE A. STATEMENT OF HYPOTHESIS AND SPECIFIC AIMS
CERVICAL CANCER SCREENING IN BOTSWANA: A ROLE FOR TELEMEDICINE A. STATEMENT OF HYPOTHESIS AND SPECIFIC AIMS A.1. Introduction Women in sub-saharan Africa often present with advanced stages of cervical
More informationStandards for Pathology Informatics in Australia (SPIA)
Standards for Pathology Informatics in Australia (SPIA) Reporting Terminology and Codes Cytopathology (v3.0) Superseding and incorporating the Australian Pathology Units and Terminology Standards and Guidelines
More informationMethods of Obstetrics & Gynecology treatment
Methods of Obstetrics & Gynecology treatment Gynecology is the medical practice dealing with the health of the female reproductive systems (vagina, uterus and ovaries) and the breasts Lector: MD Ganna
More informationAppropriate Use of Cytology and HPV Testing in the New Cervical Cancer Screening Guidelines
Appropriate Use of Cytology and HPV Testing in the New Cervical Cancer Screening Guidelines Tim Kremer, MD Ralph Anderson, MD 1 Objectives Describe the natural history of HPV particularly as it relates
More informationCytological evaluation of effusion fluid with cell block technique and cytology smears among Sudanese patients
EUROPEAN ACADEMIC RESEARCH Vol. IV, Issue 3/ June 2016 ISSN 2286-4822 www.euacademic.org Impact Factor: 3.4546 (UIF) DRJI Value: 5.9 (B+) Cytological evaluation of effusion fluid with cell block technique
More informationPredictors of Malignancy in Thyroid Fine-Needle Aspirates Cyst Fluid Only Cases
Predictors of Malignancy in Thyroid Fine-Needle Aspirates Cyst Fluid Only Cases Can Potential Clues of Malignancy Be Identified? Mohammad Jaragh, MD 1 ; V. Bessie Carydis, MMedSci (Cytol) 1 ; Christina
More informationVaginal intraepithelial neoplasia
Vaginal intraepithelial neoplasia The terminology and pathology of VAIN are analogous to those of CIN (VAIN I-III). The main difference is that vaginal epithelium does not normally have crypts, so the
More informationHPV Testing & Cervical Cancer Screening:
HPV Testing & Cervical Cancer Screening: Are they linked? By William Chapman, MD, FRCPC Screening for precursor lesions of cervical cancer by the Papanicolaou (Pap) smear has been one of the greatest success
More informationA Rare Case of Invasive Squamous Cell Carcinoma of Cervix Extending to Endometrium and Right Fallopian Tube
A Rare Case of Invasive Squamous Cell Carcinoma of Cervix Extending to Endometrium and Right Fallopian Tube Kate Madhuri S 1, Gulhane Sushma R 2, Mane Sheetal V 3 1 Professor and Head, 2 Specialist cum
More informationBleeding symptoms and subsequent risk of gynecological and other cancers
Acta Obstet Gynecol Scand 1998; 77: 564 569 Copyright C Acta Obstet Gynecol Scand 1998 Printed in Denmark all rights reserved Acta Obstetricia et Gynecologica Scandinavica ISSN 0001-6349 ORIGINAL ARTICLE
More informationAcceptable predictive accuracy of histopathology results by colposcopy done by Gynecology residents using Reid index
DOI 10.1007/s00404-012-2569-y GYNECOLOGIC ONCOLOGY Acceptable predictive accuracy of histopathology results by colposcopy done by Gynecology residents using Reid index Hadi Shojaei Fariba Yarandi Leila
More informationImproved Detection of Cervical Cancer and High Grade Neoplastic Lesions by a Combination of Conventional Cytology and DNA Automated Image Cytometer
Journal of Cancer Therapy, 2010, 1, 47-51 doi:10.4236/jct.2010.12008 Published Online June 2010 (http://www.scirp.org/journal/jct) 47 Improved Detection of Cervical Cancer and High Grade Neoplastic Lesions
More informationDiagnostic value of VIA comparing with conventional pap smear in the detection of colposcopic biopsy proved CIN
Original Article Diagnostic value of VIA comparing with conventional pap smear in the detection of colposcopic biopsy proved CIN D Hegde, H Shetty, P K Shetty, S Rai, L Manjeera, N Vyas, A Hegde, H Mallya,
More informationGynaecological Malignancies
Gynaecological Malignancies Dr Rodney Itaki Lecturer Anatomical Pathology Discipline University of Papua New Guinea Division of Pathology School of Medicine & Health Sciences Overview Genital tract tumors
More informationLessons From Cases of Screened Women Who Developed Cervical Carcinoma
Lessons From Cases of Screened Women Who Developed Cervical Carcinoma R. Marshall Austin MD,PhD Magee-Womens Hospital of University of Pittsburgh Medical Center raustin@magee.edu Why Focus Study On Cases
More informationI have no financial interests to disclose.
Workshop: Case Management of Abnormal Pap Smears and Colposcopies Rebecca Jackson, MD Professor Obstetrics, Gynecology & Reproductive Sciences and Epidemiology & Biostatistics I have no financial interests
More information